FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
19/09/2025
Voltar para busca
Dado oficial do USPTO
ZEVIPTO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
20/09/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
08/11/2023
Data de registro
18/02/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/02/2025
Última transação
20/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
CH
Examinador
CARLYLE, SHAUNIA
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Novartis AG
Representantes
Maury M. Tepper, III Tepper & Eyster, PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all of the above with the exception of pharmaceuticals for the prevention and treatment of central nervous system diseases and disorders
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/09/2025
FIMP
FINAL DISPOSITION PROCESSED
01/09/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
13/06/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/05/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
27/05/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
18/05/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
18/02/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
18/02/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/12/2024
PUBO
PUBLISHED FOR OPPOSITION
31/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/12/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/11/2024
ALIE
ASSIGNED TO LIE
06/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/08/2024
NREV
NOTICE OF REVIVAL - E-MAILED
15/08/2024
PETG
PETITION TO REVIVE-GRANTED
15/08/2024
PROA
TEAS PETITION TO REVIVE RECEIVED
15/08/2024
RFNT
REFUSAL PROCESSED BY IB
05/03/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/02/2024
RFRR
REFUSAL PROCESSED BY MPU
13/02/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/02/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/02/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/02/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/02/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/02/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/02/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/01/2024
CNRT
NON-FINAL ACTION WRITTEN
24/01/2024
MAFR
APPLICATION FILING RECEIPT MAILED
23/01/2024
DOCK
ASSIGNED TO EXAMINER
18/01/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/01/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
29/12/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/12/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ZEVIPTO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.